{"DataElement":{"publicId":"6570072","version":"1","preferredName":"Bladder Squamous Cell Carcinoma and Adenocarcinoma AJCC Edition 8 Pathologic Distant Metastasis M Category","preferredDefinition":"Extent of the distant metastasis for bladder squamous cell carcinoma and adenosarcoma based on clinical stage information combined with operative findings, and evidence obtained from pathology review when surgery is the first definitive therapy, using AJCC Ed. 8 criteria.","longName":"BSCAC_AJC8_PTH_M_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6568901","version":"1","preferredName":"Bladder Neoplasm Squamous Cell Carcinoma And Adenocarcinoma Pathologic M Category","preferredDefinition":"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra._A benign or malignant tissue growth resulting from uncontrolled cell proliferation._A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system. M refers to the presence of metastasis.","longName":"2206698v1.0:6568899v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206698","version":"1","preferredName":"Bladder Neoplasm","preferredDefinition":"A distensible musculomembranous organ serving as a receptacle for fluid, as the gallbladder.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12414:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder","conceptCode":"C12414","definition":"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-008F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6568899","version":"1","preferredName":"Squamous Cell Carcinoma And Adenocarcinoma Pathologic M Category","preferredDefinition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.:An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.:A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.:Caused by or altered by or manifesting disease or pathology.:One criteria of the TNM staging system. M refers to the presence of metastasis.","longName":"6568899v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BAA3C00-07AB-5B01-E053-F662850A8BD9","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7BAA3C00-07BC-5B01-E053-F662850A8BD9","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"TAYLORT","dateModified":"2020-12-15","changeDescription":"2020-12-15 TL released. 11-27-18 TMT created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6569764","version":"1","preferredName":"Bladder Carcinoma American Joint Committee on Cancer Edition 8 Pathologic M Category","preferredDefinition":"A pathologic finding about one or more characteristics of bladder cancer, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. M refers to the presence of metastasis._A grouping of items based on some commonality or by user defined characteristics.","longName":"6569764v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"pM1b","valueDescription":"Bladder Cancer pM1b TNM Finding v8","ValueMeaning":{"publicId":"6032979","version":"1","preferredName":"Bladder Cancer pM1b TNM Finding v8","longName":"6032979","preferredDefinition":"Bladder cancer with non-lymph node distant metastases. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pM1b TNM Finding v8","conceptCode":"C140391","definition":"Bladder cancer with non-lymph node distant metastases. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0FCA7F-0EFA-604B-E053-F662850A0A00","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BAD3077-6D02-6BD3-E053-F662850ACAA7","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"},{"value":"pM1a","valueDescription":"Bladder Cancer pM1a TNM Finding v8","ValueMeaning":{"publicId":"6032981","version":"1","preferredName":"Bladder Cancer pM1a TNM Finding v8","longName":"6032981","preferredDefinition":"Bladder cancer with distant metastasis limited to lymph nodes beyond the common iliacs. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pM1a TNM Finding v8","conceptCode":"C140390","definition":"Bladder cancer with distant metastasis limited to lymph nodes beyond the common iliacs. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0FCA7F-0F20-604B-E053-F662850A0A00","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BAD3077-6D16-6BD3-E053-F662850ACAA7","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"},{"value":"cM0","valueDescription":"Bladder Cancer cM0 TNM Finding v8","ValueMeaning":{"publicId":"6032974","version":"1","preferredName":"Bladder Cancer cM0 TNM Finding v8","longName":"6032974","preferredDefinition":"Bladder cancer without evidence of distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer cM0 TNM Finding v8","conceptCode":"C140383","definition":"Bladder cancer without evidence of distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0FA23E-AA35-5A14-E053-F662850AA1FE","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BAD3077-6D20-6BD3-E053-F662850ACAA7","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"},{"value":"cM1","valueDescription":"Bladder Cancer cM1 TNM Finding v8","ValueMeaning":{"publicId":"6032972","version":"1","preferredName":"Bladder Cancer cM1 TNM Finding v8","longName":"6032972","preferredDefinition":"Bladder cancer with distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer cM1 TNM Finding v8","conceptCode":"C140384","definition":"Bladder cancer with distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0FA23E-AA0F-5A14-E053-F662850AA1FE","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BAD3077-6D2A-6BD3-E053-F662850ACAA7","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"},{"value":"pM1","valueDescription":"Bladder Cancer pM1 TNM Finding v8","ValueMeaning":{"publicId":"6032983","version":"1","preferredName":"Bladder Cancer pM1 TNM Finding v8","longName":"6032983","preferredDefinition":"Bladder cancer with distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pM1 TNM Finding v8","conceptCode":"C140389","definition":"Bladder cancer with distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0FCA7F-0F46-604B-E053-F662850A0A00","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BAD3077-6D34-6BD3-E053-F662850ACAA7","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6569763","version":"1","preferredName":"Bladder Cancer Pathologic Distant Metastasis TNM Finding v8 American Joint Committee on Cancer M Category Category","preferredDefinition":"A pathologic finding about one or more characteristics of bladder cancer, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. M refers to the presence of metastasis.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C140388:C39315:C25727:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer Pathologic Distant Metastasis TNM Finding v8","conceptCode":"C140388","definition":"A pathologic finding about one or more characteristics of bladder cancer, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BAD3077-6CCE-6BD3-E053-F662850ACAA7","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7BAD3077-6CDF-6BD3-E053-F662850ACAA7","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"KNABLEJ","dateModified":"2019-10-31","changeDescription":"8-20-19 released per MC.; 11-27-18 TMT created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000515","version":"1","longName":"Bladder","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Pathologic M category","type":"Preferred Question Text","description":"Pathologic M category","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7BBBFB3C-224C-3266-E053-F662850A79C2","latestVersionIndicator":"Yes","beginDate":"2018-11-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-28","modifiedBy":"TAYLORT","dateModified":"2020-12-15","changeDescription":"2020-12-15 TL released. 11/28/2018 TMT created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}